These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1505739)

  • 1. Two variants of transferrable extended-spectrum TEM-beta-lactamase successively isolated from a clinical Escherichia coli isolate.
    Vedel G; Mabilat C; Goussard S; Picard B; Fournier G; Gilly L; Paul G; Philippon A
    FEMS Microbiol Lett; 1992 Jun; 72(2):161-6. PubMed ID: 1505739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
    Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
    Bradford PA; Jacobus NV; Bhachech N; Bush K
    Antimicrob Agents Chemother; 1996 Jan; 40(1):260-2. PubMed ID: 8787920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
    Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
    J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of beta-lactamases from urinary isolates of Escherichia coli in Tehran.
    Hosseini-Mazinani SM; Eftekhar F; Milani M; Ghandili S
    Iran Biomed J; 2007 Apr; 11(2):95-99. PubMed ID: 18051951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain.
    Thomson CJ; Amyes SG
    FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
    Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
    FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam.
    Collatz E; Tran Van Nhieu G; Billot-Klein D; Williamson R; Gutmann L
    Gene; 1989 May; 78(2):349-54. PubMed ID: 2506109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
    Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
    Sante; 1999; 9(6):341-4. PubMed ID: 10705312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
    Robin F; Delmas J; Schweitzer C; Tournilhac O; Lesens O; Chanal C; Bonnet R
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1304-9. PubMed ID: 17220412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2).
    Belaaouaj A; Lapoumeroulie C; Caniça MM; Vedel G; Névot P; Krishnamoorthy R; Paul G
    FEMS Microbiol Lett; 1994 Jul; 120(1-2):75-80. PubMed ID: 8056297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.
    Palzkill T; Botstein D
    J Bacteriol; 1992 Aug; 174(16):5237-43. PubMed ID: 1644749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics.
    Matar GM; Al Khodor S; El-Zaatari M; Uwaydah M
    Ann Trop Med Parasitol; 2005 Jun; 99(4):413-7. PubMed ID: 15949189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M; Pous-Miralles G; Romera-Sastre G; Panisello-Bertomeu JM; Jardí-Baiges AM; Zarazoga-López J
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):477-81. PubMed ID: 9527373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.